Our Services
Medical Information
Helpful Resources
Published on: 9/29/2026
Current evidence leans toward metformin being neutral to mildly protective rather than harmful, with most large observational studies and meta-analyses linking it to a lower risk of dementia and slower cognitive decline than other diabetes medications. The proposed benefits involve better blood sugar control, improved insulin sensitivity, reduced inflammation, and AMPK-related effects on brain aging. The important caveat is vitamin B12 deficiency, a known side effect of long-term metformin use that can itself cause memory problems, confusion, and nerve damage, which may explain why a minority of studies report higher dementia rates in certain users. No randomized trial has yet proven metformin prevents dementia, and factors like diabetes severity, duration of use, age, and monitoring of B12 levels all change the picture. There are several important details to weigh before drawing conclusions about your own situation, including warning signs that deserve prompt attention, so see below for the complete answer.
Memory changes, brain fog, tingling in the hands or feet, and fatigue can stem from medication effects, B12 deficiency, thyroid problems, poorly controlled blood sugar, sleep issues, or early neurodegenerative disease, and these causes are treated very differently. Because several of them are reversible when caught early, it is worth clarifying which pattern fits your symptoms instead of assuming the worst or dismissing it entirely. A free, instant, online symptom check can help you organize what you are experiencing, see which conditions align with your profile, and understand which questions and tests to raise with your doctor at your next visit.
Last reviewed for medical accuracy: 09/29/2026
Metformin is one of the most commonly prescribed medications for type 2 diabetes. Over the years, researchers have explored its effects beyond blood sugar control—including whether it influences the risk of dementia. This article summarizes the latest credible research to answer the question: does metformin cause dementia or might it actually protect against cognitive decline?
Dementia describes a group of symptoms affecting memory, thinking, and social abilities severely enough to interfere with daily life. Alzheimer’s disease is the most common form, but there are other types, including vascular dementia and Lewy body dementia.
Key risk factors for dementia include:
Because diabetes and insulin resistance are linked to higher dementia risk, medications that influence insulin sensitivity—like metformin—have drawn particular research interest.
Metformin lowers blood sugar primarily by:
Typical side effects include mild gastrointestinal upset. Long-term use has been associated with vitamin B12 deficiency in up to 30% of users, which can lead to anemia and, in rare cases, cognitive symptoms if untreated.
A growing body of research suggests metformin might have neuroprotective effects:
Observational Cohort Studies
Meta-Analyses
Possible Mechanisms
These findings are promising, but most come from observational studies, which can’t fully prove cause and effect. Factors such as healthier lifestyle choices among metformin users might also contribute.
Despite evidence for protection, some studies have raised potential concerns:
Vitamin B12 Deficiency
Conflicting Observations
Overall, the consensus among diabetes and neurology experts is that metformin itself is unlikely to directly cause dementia. Instead, secondary effects—particularly B12 deficiency—could contribute to mild cognitive symptoms in some individuals.
When we weigh the data:
Talk to your doctor about routine labs:
Maintain a brain-healthy lifestyle:
Watch for warning signs:
If you notice new or worsening cognitive symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker, to help guide your next steps.
Always discuss any concerning or life-threatening symptoms with a qualified healthcare provider. If you experience:
…please speak to a doctor promptly or visit your nearest emergency department.
If you have questions about metformin, dementia risk, or any new symptoms, talk with your healthcare team. Staying proactive—through regular checkups, lab monitoring, and healthy lifestyle choices—remains the best strategy for both metabolic and brain health.
¹ Foo J et al. Atherosclerosis (2019)
² Smith P et al. JAMA Neurology (2020)
³ Lee H et al. Diabetes Research and Clinical Practice (2021)
⁴ de Jager J et al. Diabetes Care (2010)
⁵ Zhang X et al. Aging Clinical and Experimental Research (2017)
(References)
* Markowicz-Piasecka M, Sikora J, Szydłowska A, Skupień A, Mikiciuk-Olasik E, Huttunen KM. Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla. Pharm Res. 2017 Dec;34(12):2614-2627. doi: 10.1007/s11095-017-2199-y. Epub 2017 Jun 6. PMID: 28589443; PMCID: PMC5736777.
* Oliveira WH, Braga CF, Lós DB, Araújo SMR, França MR, Duarte-Silva E, Rodrigues GB, Rocha SWS, Peixoto CA. Metformin prevents p-tau and amyloid plaque deposition and memory impairment in diabetic mice. Exp Brain Res. 2021 Sep;239(9):2821-2839. doi: 10.1007/s00221-021-06176-8. Epub 2021 Jul 20. PMID: 34283253.
* Khezri MR, Yousefi K, Mahboubi N, Hodaei D, Ghasemnejad-Berenji M. Metformin in Alzheimer's disease: An overview of potential mechanisms, preclinical and clinical findings. Biochem Pharmacol. 2022 Mar;197:114945. doi: 10.1016/j.bcp.2022.114945. Epub 2022 Feb 5. PMID: 35134385.
* Charpignon ML, Vakulenko-Lagun B, Zheng B, Magdamo C, Su B, Evans K, Rodriguez S, Sokolov A, Boswell S, Sheu YH, Somai M, Middleton L, Hyman BT, Betensky RA, Finkelstein SN, Welsch RE, Tzoulaki I, Blacker D, Das S, Albers MW. Causal inference in medical records and complementary systems pharmacology for metformin drug repurposing towards dementia. Nat Commun. 2022 Dec 10;13(1):7652. doi: 10.1038/s41467-022-35157-w. Epub 2022 Dec 10. PMID: 36496454; PMCID: PMC9741618.
* Xu S, Zheng B, Su B, Finkelstein SN, Welsch R, Ng K, Shahn Z. Can metformin prevent cancer relative to sulfonylureas? A target trial emulation accounting for competing risks and poor overlap via double/debiased machine learning estimators. Am J Epidemiol. 2025 Feb 5;194(2):512-523. doi: 10.1093/aje/kwae217. PMID: 39030720.
* Schwartz SS, Herman ME, Tun MTH, Barone E, Butterfield DA. The double life of glucose metabolism: brain health, glycemic homeostasis, and your patients with type 2 diabetes. BMC Med. 2024 Dec 18;22(1):582. doi: 10.1186/s12916-024-03763-8. Epub 2024 Dec 18. PMID: 39696300; PMCID: PMC11657227.
* Li Z, Lin C, Cai X, Lv F, Yang W, Ji L. Anti-diabetic agents and the risks of dementia in patients with type 2 diabetes: a systematic review and network meta-analysis of observational studies and randomized controlled trials. Alzheimers Res Ther. 2024 Dec 23;16(1):272. doi: 10.1186/s13195-024-01645-y. Epub 2024 Dec 23. PMID: 39716328; PMCID: PMC11668108.
* Enderami A, Shariati B, Zarghami M, Aliasgharian A, Ghazaiean M, Darvishi-Khezri H. Metformin and Cognitive Performance in Patients With Type 2 Diabetes: An Umbrella Review. Neuropsychopharmacol Rep. 2025 Mar;45(1):e12528. doi: 10.1002/npr2.12528. PMID: 39871536; PMCID: PMC11772738.
* Zhang D, He X, Wang Y, Wang X, Han X, Liu H, Xing Y, Jiang B, Xiu Z, Bao Y, Dong Y. Hesperetin-Enhanced Metformin to Alleviate Cognitive Impairment via Gut-Brain Axis in Type 2 Diabetes Rats. Int J Mol Sci. 2025 Feb 23;26(5). doi: 10.3390/ijms26051923. Epub 2025 Feb 23. PMID: 40076550; PMCID: PMC11900253.
* Alameen AAM, Al-Kuraishy HM, Abdelaziz AM, Al-Gareeb AI, Albuhadily AK, Batiha GE. Targeting PARP1-dependent parthanatos in Alzheimer's disease: Mechanisms and therapeutic opportunities. Life Sci. 2026 Oct 1;402:124578. doi: 10.1016/j.lfs.2026.124578. Epub 2026 Jul 7. PMID: 42413719.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.